These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Analysis of the prevalence of HBV markers relevant to the risk of reactivation of infection in patients with hematologic diseases].
    Author: Kopacz A, Bielecka A, Mikulska M, Grabarczyk P, Zwolińska P, Wojciechowska B, Łetowska M, Kisiel E, Warzocha K, Ceglarek B, Szczepanik AB, Szczepiński A, Owczarska K, Pielaciński K, Brojer E.
    Journal: Przegl Epidemiol; 2012; 66(1):1-5. PubMed ID: 22708290.
    Abstract:
    The study assessed the incidence of HBV markers (HBsAg, anti-HBc, anti-HBs) important for determination of the risk of reactivation of infection, with particular interest of occult infection (presence of HBV DNA in the absence of HBsAg) in patients treated at the Institute of Hematology and Transfusion Medicine. Anti-HBc frequency was correlated with the age and sex of patients. HBsAg was detected in 16/468 examined patients, 98/468 (21%) were anti-HBc positive. HBV DNA was detected in 41/98 anti-HBc positives; in 13 simultaneously with HBsAg. 28 patients had occult HBV infection (HBV DNA+/HBsAg). Antibody to HBsAg was detected in 163/430 (38%) patients, 81 out of them on protective level (> 100 IU/l). It was shown that occult HBV infection occurs in approximately 6% of patients. In most of them the protective levels of anti-HBs are detected.
    [Abstract] [Full Text] [Related] [New Search]